Chemoinformaics analysis of 2-METHYL-PYRIDINE
| Molecular Weight | 93.129 | nRot | 0 |
| Heavy Atom Molecular Weight | 86.073 | nRig | 6 |
| Exact Molecular Weight | 93.0578 | nRing | 1 |
| Solubility: LogS | 0.823 | nHRing | 1 |
| Solubility: LogP | 0.965 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 15.7876 |
| nHD | 0 | BPOL | 8.16245 |
| QED | 0.472 |
| Synth | 1.556 |
| Natural Product Likeliness | -1.959 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.163 |
| MDCK | 0.0000384 |
| BBB | 0.826 |
| PPB | 0.313816 |
| VDSS | 2.078 |
| FU | 0.620604 |
| CYP1A2-inh | 0.469 |
| CYP1A2-sub | 0.53 |
| CYP2c19-inh | 0.079 |
| CYP2c19-sub | 0.733 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.245 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.645 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.294 |
| CL | 5.861 |
| T12 | 0.541 |
| hERG | 0.022 |
| Ames | 0.105 |
| ROA | 0.656 |
| SkinSen | 0.71 |
| Carcinogencity | 0.479 |
| EI | 0.996 |
| Respiratory | 0.952 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.901349 |